Live Attenuated Influenza Vaccine No Better Than Inactivated

Share this content:
Live Attenuated Influenza Vaccine No Better Than Inactivated
Live Attenuated Influenza Vaccine No Better Than Inactivated

TUESDAY, Aug. 16, 2016 (HealthDay News) -- Immunizing children with intranasal live attenuated influenza vaccine (LAIV) does not appear to provide better protection against influenza than inactivated influenza vaccine (IIV), according to a study published online Aug. 16 in the Annals of Internal Medicine.

Mark Loeb, M.D., from McMaster University in Hamilton, Canada, and colleagues conducted a cluster randomized blinded trial over three influenza seasons in 52 Hutterite colonies in Canada. The study population comprised 1,186 Canadian children and adolescents aged 36 months to 15 years who received the study vaccine, and 3,425 community members who did not receive the vaccine. Children were randomized according to community to receive standard dosing of trivalent LAIV or trivalent IIV.

The researchers found that the mean vaccine coverage was 76.7 and 72.4 percent among children in the LAIV and IIV groups, respectively. Influenza virus infection occurred at a rate of 5.3 and 5.2 percent in the LAIV and IIV groups, respectively. For influenza A or B virus, the hazard ratio comparing LAIV with IIV was 1.03 (95 percent confidence interval, 0.85 to 1.24).

"Immunizing children with LAIV does not provide better community protection against influenza than IIV," the authors write.

One author disclosed financial ties to the pharmaceutical industry.

Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters


More in Home

FDA Approves First Drug for Rare Form of Rickets

FDA Approves First Drug for Rare Form of ...

Crysvita approved for adults and children ages 1 year and older with x-linked hypophosphatemia

High FGF-23 Linked to Recurrent Cardiac Events After ACS

High FGF-23 Linked to Recurrent Cardiac Events After ...

FGF-23 in top quartile independently linked to greater risk of CV death, heart failure hospitalization

Medical Cannabis Not Recommended for Sleep Apnea

Medical Cannabis Not Recommended for Sleep Apnea

American Academy of Sleep Medicine says evidence insufficient to recommend cannabis for apnea

is free, fast, and customized just for you!

Already a member?

Sign In Now »